CVD risk in axSpA – Nigil Haroon SPARTAN-GRAPPA-ASAS Symposium #ACR17 pic.twitter.com/BtpXBszcUb
— Marco S Massarotti (@msmassarotti) November 8, 2017
Big Take Home Message from #ACR17 on influenza vaccination- AT Next MTX FUV- give the flu vaccine AND HOLD MTX for 2 weeks (Plenary Session) by Park et al. https://t.co/grfLQx0CYN pic.twitter.com/A3xOyZOu5m
— Dr. John Cush (@RheumNow) November 9, 2017
Dr. Shashank Akerkar: New Molecules in Psoriatic Arthritis
Dr. Philip Robinson: Osteoarthritis and Inflammation
No difference in lung safety of Abatacept and TNFI and one study of more ILD with IFX vs ABA #137. #acr17 @rheumnow #526 pic.twitter.com/ugYBF7THKa
— Janet (@Janetbirdope) November 8, 2017
JHU experience with Rheumatic irAEs: inflammatory arthritis features differ by ICI regimen #2902 @cappelliMD @RheumNow #ACR17
— Cassandra Calabrese (@CCalabreseDO) November 8, 2017
#GAMECHANGER. Steroids cost more in rheumatic diseases; dose dependent Limit or reduce dose. #acr17 @rheumnow #1801
— Janet (@Janetbirdope) November 8, 2017
Dr. Janet Pope: Therapy Effect on Radiographic Progression
Think you know septic arthritis? Revolutionary insights from Ziv Paz. Come to 6D at 11am. #ACR17 pic.twitter.com/4kGScGQkjZ
— Jonathan Hausmann MD (@hausmannMD) November 8, 2017
Steroid tapering/discontinuation suggestions in JDM, ? best predictors of clinical remission. #ACR17 @RheumNow #2956 https://t.co/U7UQTD1hnj pic.twitter.com/shk6fOThlh
— Dr. Rachel Tate (@uptoTate) November 8, 2017
Rheum Rockstars playing to a packed house! Thanks @RheumNow and Dr. K you are a highlight of #ACR17 #RheumRoundUp pic.twitter.com/8MpdYgdutV
— Donna Hoyne (@donna_hoyne) November 8, 2017
Dr. Len Calabrese: Herpes Zoster
Dr. Julio Gonzalez: Radiographic Progression in Psoriatic Arthritis
Oral steroids >10mg/ day doubles the risk for both postoperative and prosthetic infection. No differences across anti-TNFs #ACR17
— jonathan marks (@dr_jonmarks) November 7, 2017
The use of low dose aspirin as primary prevention of CV events in RA had similar risk of major NSAID toxicity and MACE as patients not on it. A larger cohort will be needed to confirm use of low dose aspirin for primary prevention of CV events in RA, Solomon #ACR17
— Dr. Antoni Chan (@synovialjoints) November 7, 2017
The type of Immune checkpoint inhibitors affects type and distribution of joints affected, autoantibodies may not always be positive #ACR17
— Dr. Antoni Chan (@synovialjoints) November 7, 2017
Radiologic or histology NSIl or OP in an young person raises questions of CTD-ILD #ACR17
— Suleman Bhana, MD (@DrBhana) November 8, 2017
HCQ screening recommendations from the American Academy of ophthalmology #2016revision#ACR17 #HCQ#reviewcourse pic.twitter.com/iXwWD83OTM
— V. Ocampo D (@VOD_MD) November 4, 2017
@RheumNow Still’s doesn’t kill patients, immunosuppressants and MAS do #acr17 #AOSD #periodicfeversyndromes pic.twitter.com/uZlIEHmlu1
— Olga Petryna (@DrPetryna) November 8, 2017
Dr. Rachel Tate: Adalimumab and Disease Remission
Dr. Philip Mease: FUTURE 5 Study
Dr. Paul Sufka: Pregnancy and Treatment
Dr. Jack Cush and Dr. Pete Salzmann (Eli Lilly and Company): Pain as a Differentiator
“No country is safe from Dengue” – Rohini Handa #ACR17 @RheumNow @HealioRheum pic.twitter.com/nG7drifaMb
— Cassandra Calabrese (@CCalabreseDO) November 7, 2017
@LCalabreseDO talks Zika for the rheumatologist: short-lived arthralgia hands&feet, worse if pre-existing RA @RheumNow @HealioRheum #ACR17 pic.twitter.com/WySlfcjjze
— Cassandra Calabrese (@CCalabreseDO) November 7, 2017
Inflammatory arthritis treatment in immune related adverse events to checkpoint inhibitors #ACR17 @RheumNow pic.twitter.com/UuRG4MKYeY
— Philip Robinson (@philipcrobinson) November 7, 2017
Not sure what to use as Rx after pt has cancer. Meta analysis has mostly expert opinion. #acr17 @rheumnow #2395 pic.twitter.com/DdCNDfGeBi
— Janet (@Janetbirdope) November 7, 2017
Vere low incidence of HCQ maculopathy/No blindness seen in large pt cohort
L8#ACR17 @RheumNow pic.twitter.com/H12ebizr9L— Julio Gonzalez (@japaoli19) November 7, 2017
#11L
RApts with cancer hx on biologics-no increased risk of a 2nd malignancy compared to untreated pts#ACR17 @rheumnow pic.twitter.com/pMqNKXXaBy— Julio Gonzalez (@japaoli19) November 7, 2017
#GAMECHANGER. If not responding to tociluzimab in RA you can respond to switch to 200 mg sarilab #acr17 @rheumnow #2468 pic.twitter.com/SwinP50HT3
— Janet (@Janetbirdope) November 7, 2017
Addition of Steroid Rx to bDMARDs increases risk of post op infections. Effect dose depended #ACR17 #2755 @RheumNow pic.twitter.com/gELV2IriLc
— Olga Petryna (@DrPetryna) November 7, 2017
Good news for HCQ: still appears that clinically significant toxicity remains rare. #ACR17 @RheumNow #8L pic.twitter.com/04wLgCj07m
— Dr. Paul Sufka (@psufka) November 7, 2017
No increased risk of second malignancy in RA patients on biologics. #ACR17 @RheumNow #11L pic.twitter.com/YUfehZgzg8
— Dr. Paul Sufka (@psufka) November 7, 2017
Serious infections in RA more associated with disease activity than DMARDs/biologics. #ACR17 @RheumNow #2410 pic.twitter.com/rq050WvnPJ
— Dr. Paul Sufka (@psufka) November 7, 2017
#16L #acr17 no risk of DVTorPE w/Tofa from RTC trials analysis. IRs comparable to #corona data for Tofa&cDMARDs @RheumNow pic.twitter.com/7Z2LclfE5m
— Olga Petryna (@DrPetryna) November 7, 2017
Effect of live HZ vaccine in MTX-IR w/RA getting tofa or ADA +/- MTX: well-tolerated, higher HZ rates in tofa+MTX #2393 #ACR17 @RheumNow
— Cassandra Calabrese (@CCalabreseDO) November 7, 2017
Danish registry: no increase risk of 2nd malignancy on biologics #11L #ACR17 @rheumnow
— k dao (@KDAO2011) November 7, 2017
Dr. Kathryn Dao: FDA Warnings and Precision Medicine
Dr. Ian Bruce: Lupus and Vasculitis
Dr. Janet Pope: JAK 2 Inhibitor Controversy
Dr. Ken Saag: Update on Gout Therapy
Dr. David Borenstein: Pain
Adalimumab pregnancy update. FDA Year in Review session. #ACR17 >FB pic.twitter.com/eKMfWjv8lJ
— francis berenbaum (@Larhumato) November 6, 2017
Fentanyl, not heroin, drove 2016 surge in drug-overdose deaths, C.D.C. says. https://t.co/Y4ded85biM
— NYT Health (@NYTHealth) November 7, 2017
Crib study shows no detectable levels of CZP on infants umbilical cords#ACR17 @RheumNow pic.twitter.com/7C1ctxv76c
— Julio Gonzalez (@japaoli19) November 7, 2017